Skip to content

Rehabilitation of Patients After Subarachnoid Hemorrhage

Effect of Early Rehabilitation in Patients With Acute Subarachnoid Hemorrhage

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01656317
Acronym
SAH
Enrollment
171
Registered
2012-08-02
Start date
2012-01-01
Completion date
2015-12-20
Last updated
2017-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SAH

Keywords

SAH, Early rehabilitation, Mobilisation

Brief summary

The study's main objective will be to assess which effect early initiated rehabilitation has on the frequency of complications and the level of physical and cognitive functioning after aneurysmal subarachnoid hemorrhage (SAH). To this end the following aspects will be investigated: The frequency of complications (with special emphasis on pulmonary complications,thromboembolic events, cerebral vasospasm, unintended discontinuation of drains and lines) * Length of stay in hospitals and socio-economic impact * Physical and cognitive function in the early and chronic phase after SAH * Health-related quality of life and participation in society in the chronic phase

Detailed description

Oslo University Hospital (OUS) is the primary hospital for Health Region South-East regarding treatment of patients with SAH. Approximately 120 patients are referred annually. OUS,Rikshospitalet, Dept of Neurosurgery offers 24/7 service of surgical and vascular aneurysm repair performed by a dedicated vascular team. Patients admitted in 2012 are treated in accordance to the standard institutional protocol plus an early rehabilitation model adapted to SAH, while patients admitted in 2011 who did not receive any early rehabilitation, but apart from that were treated identically, serve as a control group. All patients admitted to the intermediate unit at OUS in 2011 and 2012 with aneurysmal SAH and repaired aneurysm will be invited to participate in this study. Examination of the patients from both 2011 and 2012 will be performed as part of routine, neurosurgical follow- up which is in the early phase at 3-6 months and in the chronic phase at least 12 months post SAH. Exclusion criteria for participation in the study: unsecured ruptured aneurysm, symptomatic aneurysm without rupture, previous SAH or brain injury, diagnosis of a neurodegenerative disorder, patients from other health regions or tourists, patients that were treated at the intensive care unit (ICU )only.

Interventions

OTHEREarly multidisciplinary rehabilitation

Multidisciplinary rehabilitation consist of individualized stimulation and mobilisation. The multidisciplinary team consists of a physician, a nurse, a physiotherapist, an occupational therapist and a clinical neuropsychologist.

Sponsors

Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients admitted to the intermediate unit at OUS in 2011 and 2012 with aneurysmal SAH and repaired aneurysm will be invited to participate in this study.

Exclusion criteria

* Unsecured ruptured aneurysm, * Symptomatic aneurysm without rupture * Previous SAH or brain injury, diagnosis of a neurodegenerative disorder * Patients from other health regions or tourists * Patients that were treated at the intensive care unit (ICU )only.

Design outcomes

Primary

MeasureTime frame
Glasgow Coma Scale (GCS)up to 10 weeks

Secondary

MeasureTime frame
Glasgow Outcome Scale Extended (GOSE)3-6 months and 12 months after SAH
Functional Independence Measure (FIM)3-6 months and 12 months after SAH
Disability Rating Scale (DRS)3-6 and 12 months after SAH
High Level Mobility Assessment Tool (HIMAT)3-6 and 12 months after SAH
Coma Recovery Scale (CRS)3-6 and 12 months after SAH

Other

MeasureTime frame
Pain score on the Visual Analog Scale3-6 and 12 months after SAH

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026